Rho-kinase inhibitor Y-27632 and hypoxia synergistically enhance chondrocytic phenotype and modify S100 protein profiles in human chondrosarcoma cells
Abstract Articular chondrocytes are slowly dividing cells that tend to lose their cell type-specific phenotype and ability to produce structurally and functionally correct cartilage tissue when cultured. Thus, culture conditions, which enhance the maintenance of chondrocyte phenotype would be very u...
Guardado en:
Autores principales: | Juha Piltti, Joakim Bygdell, Cecilia Fernández-Echevarría, Daniel Marcellino, Mikko J. Lammi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/293a096374814e7e8467ae0f6f0fd064 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hypoxia regulates RhoA and Wnt/β-catenin signaling in a context-dependent way to control re-differentiation of chondrocytes
por: Ece Öztürk, et al.
Publicado: (2017) -
Peptide substrates for Rho-associated kinase 2 (Rho-kinase 2/ROCK2).
por: Jeong-Hun Kang, et al.
Publicado: (2011) -
Failure of Y-27632 to improve the culture of adult human adipose-derived stem cells
por: Lamas NJ, et al.
Publicado: (2015) -
Cellular responses to T-2 toxin and/or deoxynivalenol that induce cartilage damage are not specific to chondrocytes
por: Yang Lei, et al.
Publicado: (2017) -
An emerging treatment option for glaucoma: Rho kinase inhibitors
por: Wang SK, et al.
Publicado: (2014)